We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+11.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$42.5B
AUM Growth
+$3.46B
(+8.8%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
48.81%
Holding
311
New
17
Increased
72
Reduced
106
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$542M |
| 2 |
Microsoft
MSFT
|
+$231M |
| 3 |
Blackstone
BX
|
+$104M |
| 4 |
Caterpillar
CAT
|
+$98M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$90.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$150M |
| 2 |
Intuit
INTU
|
+$141M |
| 3 |
ASML
ASML
|
+$124M |
| 4 |
Intuitive Surgical
ISRG
|
+$120M |
| 5 |
Verisk Analytics
VRSK
|
+$96.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Financials | 17.95% |
| 3 | Consumer Staples | 10.49% |
| 4 | Communication Services | 9.83% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Stryker
SYK
$118B
| $761K | ﹤0.01% |
2,417
-234
| -9% | -$73.7K |
|
202
Integer Holdings
ITGR
$4.27B
| $755K | ﹤0.01% |
8,082
-1,496
| -16% | -$133K |
|
203
AT&T
T
$179B
| $747K | ﹤0.01% |
36,063
+1,221
| +4% | +$30.3K |
|
204
CVS Health
CVS
$124B
| $731K | ﹤0.01% |
7,070
+297
| +4% | +$26.5K |
|
205
Eagle Materials
EXP
$5.94B
| $714K | ﹤0.01% |
3,175
+750
| +31% | +$157K |
|
206
Unilever
UL
$138B
| $707K | ﹤0.01% |
11,766
| – | – |
|
207
Parker-Hannifin
PH
$122B
| $688K | ﹤0.01% |
703
| – | – |
|
208
O'Reilly Automotive
ORLY
$70.7B
| $686K | ﹤0.01% |
7,445
-739
| -9% | -$67.4K |
|
209
Selective Insurance
SIGI
$5.55B
| $664K | ﹤0.01% |
6,846
| – | – |
|
210
Kimberly-Clark
KMB
$35.9B
| $661K | ﹤0.01% |
6,021
-250
| -4% | -$24.8K |
|
211
Ecolab
ECL
$78.2B
| $648K | ﹤0.01% |
2,326
-276
| -11% | -$72.7K |
|
212
Western Midstream Partners
WES
$20.3B
| $643K | ﹤0.01% |
14,704
| – | – |
|
213
Manulife Financial
MFC
$73.9B
| $632K | ﹤0.01% |
15,593
| – | – |
|
214
Halliburton
HAL
$31.1B
| $629K | ﹤0.01% |
18,540
+2,000
| +12% | +$78.1K |
|
|
GRMN
215
Garmin
GRMN
$53.5B
| $624K | ﹤0.01% |
2,627
| – | – |
|
216
Prosperity Bancshares
PB
$8.7B
| $598K | ﹤0.01% |
8,188
| – | – |
|
217
Archer Daniels Midland
ADM
$40.7B
| $596K | ﹤0.01% |
7,800
| – | – |
|
218
Halozyme
HALO
$12.6B
| $587K | ﹤0.01% |
7,500
| – | – |
|
219
SEI Investments
SEIC
$13.4B
| $585K | ﹤0.01% |
6,675
| – | – |
|
220
Ball Corp
BALL
$16.7B
| $580K | ﹤0.01% |
9,300
| – | – |
|
221
Trane Technologies
TT
$98B
| $575K | ﹤0.01% |
1,171
| – | – |
|
222
United Rentals
URI
$61.9B
| $566K | ﹤0.01% |
500
| – | – |
|
223
Moody's
MCO
$87.3B
| $544K | ﹤0.01% |
1,200
| – | – |
|
224
Teradyne
TER
$52.9B
| $532K | ﹤0.01% |
1,100
| – | – |
|
|
FISV
225
Fiserv Inc
FISV
$28B
| $527K | ﹤0.01% |
10,753
| – | – |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q2 2026 Portfolio in Review
As of Q2 2026, Fayez Sarofim & Co held 311 positions worth $42.5B, up 8.8% from $39.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Fayez Sarofim & Co's Q2 2026 filing shows 17 new, 72 increased, 106 reduced and 11 closed positions. Its largest new stake was AstraZeneca: 179,593 shares worth $34.1M. The largest sale was Texas Instruments, an estimated $150M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q2 2026 buy was AstraZeneca: 179,593 shares worth $34.1M.
- Fayez Sarofim & Co added most to Broadcom in Q2 2026, an estimated $542M increase.
- Fayez Sarofim & Co's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $150M.
- Fayez Sarofim & Co fully exited HDFC Bank in Q2 2026, selling an estimated $8.97M.
- Fayez Sarofim & Co's ten largest holdings make up 49% of its $42.5B portfolio in Q2 2026.
- Fayez Sarofim & Co opened 17 new positions and closed 11 in Q2 2026.
- Fayez Sarofim & Co's portfolio value rose 8.8% quarter-over-quarter to $42.5B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.